Emerging Markets led global returns in 2025, but India lagged due to outflows and weaker earnings. With valuations correcting and domestic fundamentals strengthening, including policy support and rising retail participation, India is positioned for a potential rebound. Structural drivers suggest the underperformance could set the stage for stronger market performance in 2026.
Dr Reddy’s shares slide 7% after delay in semaglutide supplies over quality concerns
Dr Reddy’s shares fell sharply on Thursday after the company delayed commercial supplies of its semaglutide product due to a quality issue involving the active